Clinical Trial

Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days

Study acronym: RAPID5
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adherence and can be very time-consuming. As such, alternative interventions are needed. Transcranial magnetic stimulation (TMS) has been FDA-cleared for depression since 2008 and has recently been cleared to treat smoking cessation and obsessive-compulsive disorder. It has demonstrated promise for reducing PTSD symptom severity but standard TMS has a significant time requirement. This study will compare an accelerated 5-day form of TMS versus sham for PTSD, characterizing efficacy and durability. This project will provide important information that can be implemented in the near term for Veterans with PTSD.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2030-06-30 -> 2030-09-30 2026-07-28
minor Completion pushed: 2030-07-01 -> 2030-12-06 2026-07-28
Trial Details
NCT Number NCT07167940
Lead Sponsor VA Office of Research and Development
Conditions PTSD
Enrollment 90 participants
Start Date 2026-10-01
Primary Completion 2030-09-30 (estimated)
Study Completion 2030-12-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-29